Article

Severe Diffuse Ulcerative Esophagitis Following Enfortumab Vedotin and Pembrolizumab in Metastatic Urothelial Carcinoma: A Case Report

2026-07-09

Abstract excerpt

<h4>Background: </h4> Enfortumab vedotin combined with pembrolizumab has emerged as an effective first-line therapy for advanced urothelial carcinoma. While immune checkpoint inhibitors are associated with gastrointestinal toxicities, upper gastrointestinal involvement such as esophagitis remains rare, and its presentation in combination with enfortumab vedotin is not well characterized. Case Presentation: A 72-y...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d1a2e252-8b91-5146-baf2-4321afe56f96
DOI: 10.20944/preprints202607.0654.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Severe Diffuse Ulcerative Esophagitis Following Enfortumab Vedotin and Pembrolizumab in Metastatic Urothelial Carcinoma: A Case ReportDOI 10.20944/preprints202607.0654.v1Read

Comparison of the Efficacy of Enfortumab Vedotin between patients with Metastatic Urothelial Carcinoma who were treated with Avelumab or Pembrolizumab: Real-World Data from a Multi-Institutional Study in JapanSemantic proximity Read

Nivolumab-associated DRESS in a genetic susceptible individual.Semantic proximity Read

Paraneoplastic Erythroderma as the Initial Manifestation of Advanced Colorectal Carcinoma: A Case ReportSemantic proximity Read

Pembrolizumab-associated eosinophilic polyserositis with pericardial involvement during adjuvant therapy for clear cell renal cell carcinoma: a case report and narrative reviewSemantic proximity Read

Nasogastric administration of osimertinib suspension for an epidermal growth factor receptor-mutated lung cancer causing an esophageal stricture: case report.Semantic proximity Read

Scratching the Surface: NECTIN-4 as a Surrogate for Enfortumab Vedotin ResistanceSemantic proximity Read

Osimertinib tolerance in a patient with Stevens Johnson Syndrome during Osimertinib treatment followed by PembrolizumabSemantic proximity Read

Case Report: Fatal myocarditis after combination of immune checkpoint inhibitor and platinum doublet chemotherapySemantic proximity Read

Herpes simplex esophagitis in the immunocompetent hostSemantic proximity Read

Successful Treatment of Metastatic Upper Tract Urothelial Carcinoma With Vemurafenib: Case Report.Semantic proximity Read

Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma.Semantic proximity Read

Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapy.Semantic proximity Read